Presenter beside an illustrative clinical-trial facility and study relationship diagram

How Massachusetts Biotech Teams Reconcile Clinical-Trial Site Accounts in Salesforce

Why Do Trial-Site Name Variants Matter to Massachusetts Biotech Teams?

In this anonymized composite scenario, a Massachusetts biotech sponsor imports clinical-trial facility records from a registry and two CRO feeds into Salesforce. Variant names create duplicate Site Accounts, while a broad name match risks collapsing separate campuses. An illustrative 15,000-row review shows how the team can verify each physical facility, preserve separate study-site relationships, preview approved ZaapIT corrections, and retain backup, bulk undo, and restore for supported updates. This is not a named customer result.

Presenter beside an illustrative clinical-trial facility and study relationship diagram
Illustrative visual: one verified physical facility can participate in several distinct studies.

Read More

Presenter explaining clean Salesforce institution and contact data for Massachusetts life sciences

How Massachusetts Life Sciences Teams Clean Institution Data Safely

Why Institution Data Hygiene Matters for Massachusetts Life Sciences

A Massachusetts biotechnology company sees the same hospital, university, laboratory, and research partner represented by several Accounts while investigators, procurement contacts, and commercial stakeholders are attached to inconsistent records. Reports overcount institutions and hide the real relationship network. This anonymized composite scenario shows how an admin can profile 15,000 Account, Contact, and relationship rows, clean them with ZaapIT, validate the hierarchy, and retain bulk undo and restore for affected records.

Presenter explaining clean Salesforce institution and contact data for Massachusetts life sciences
Illustrative visual: a Massachusetts life-sciences team reviews institution and contact data. Screen values are examples, not measured customer results.

Read More